• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外tau 纤维形成的特征。

Characterization of tau fibrillization in vitro.

机构信息

The Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, and Institute on Aging, University of Pennsylvania School of Medicine, Philadelphia, USA.

出版信息

Alzheimers Dement. 2010 Mar;6(2):110-7. doi: 10.1016/j.jalz.2009.06.002.

DOI:10.1016/j.jalz.2009.06.002
PMID:20298971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2842604/
Abstract

BACKGROUND

The assembly of tau proteins into paired helical filaments, the building blocks of neurofibrillary tangles, is linked to neurodegeneration in Alzheimer's disease and related tauopathies. A greater understanding of this assembly process could identify targets for the discovery of drugs to treat Alzheimer's disease and related disorders. By using recombinant human tau, we have delineated events leading to the conversion of normal soluble tau into tau fibrils.

METHODS

Atomic force microscopy and transmission electron microscopy methodologies were used to determine the structure of tau assemblies that formed when soluble tau was incubated with heparin for increasing lengths of time.

RESULTS

Tau initially oligomerizes into spherical nucleation units of 18- to 21-nm diameter that appear to assemble linearly into nascent fibrils. Among the earliest tau fibrils are species that resemble a string of beads formed by linearly aligned spheres that with time seem to coalesce to form straight and twisted ribbon-like filaments, as well as paired helical filaments similar to those found in human tauopathies. An analysis of fibril cross sections at later incubation times revealed three fundamental axial structural features.

CONCLUSIONS

By monitoring tau fibrillization, we showed that different tau filament morphologies coexist. Temporal changes in the predominant tau structural species suggest that tau fibrillization involves the generation of structural intermediates, resulting in the formation of tau fibrils with verisimilitude to their authentic human counterparts.

摘要

背景

tau 蛋白组装成双螺旋丝,这是神经原纤维缠结的结构基础,与阿尔茨海默病和相关 tau 病的神经退行性变有关。对这一组装过程的深入了解可以确定靶点,从而发现治疗阿尔茨海默病和相关疾病的药物。通过使用重组人 tau,我们描绘了导致正常可溶性 tau 转化为 tau 纤维的过程。

方法

原子力显微镜和透射电子显微镜方法用于确定可溶性 tau 与肝素孵育不同时间后形成的 tau 组装体的结构。

结果

tau 最初寡聚形成 18-21nm 直径的球形核形成单位,这些单位似乎在线性组装成新生纤维。最早的 tau 纤维中存在一些类似珠子串的物种,这些珠子由线性排列的球体形成,随着时间的推移,它们似乎融合在一起,形成直的和扭曲的带状纤维,以及类似于人类 tau 病中发现的双螺旋丝。对后期孵育时间的纤维横截面进行分析,揭示了三个基本的轴向结构特征。

结论

通过监测 tau 的纤维化过程,我们表明不同的 tau 纤维形态共存。tau 主要结构物种的时间变化表明 tau 纤维化涉及结构中间产物的产生,导致形成与真实 tau 纤维相似的 tau 纤维。

相似文献

1
Characterization of tau fibrillization in vitro.体外tau 纤维形成的特征。
Alzheimers Dement. 2010 Mar;6(2):110-7. doi: 10.1016/j.jalz.2009.06.002.
2
Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau.表达突变型(P301L)人tau蛋白的转基因小鼠的超微结构神经元病理学
J Neurocytol. 2003 Nov;32(9):1091-105. doi: 10.1023/B:NEUR.0000021904.61387.95.
3
Tau (297-391) forms filaments that structurally mimic the core of paired helical filaments in Alzheimer's disease brain.Tau(297-391)形成的纤维在结构上模拟了阿尔茨海默病大脑中双螺旋丝的核心。
FEBS Lett. 2020 Mar;594(5):944-950. doi: 10.1002/1873-3468.13675. Epub 2019 Dec 1.
4
Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation.新型人神经元 tau 模型,表现出神经纤维缠结和细胞间传播。
Neurobiol Dis. 2017 Oct;106:222-234. doi: 10.1016/j.nbd.2017.06.005. Epub 2017 Jun 10.
5
Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice.来自阿尔茨海默病大脑的独特病理性tau构象在非转基因小鼠中传播tau病理。
J Exp Med. 2016 Nov 14;213(12):2635-2654. doi: 10.1084/jem.20160833. Epub 2016 Oct 17.
6
In vitro comparison of major memory-support dietary supplements for their effectiveness in reduction/inhibition of beta-amyloid protein fibrils and tau protein tangles: key primary targets for memory loss.体外比较主要的记忆支持膳食补充剂对β-淀粉样蛋白纤维和tau 蛋白缠结的减少/抑制作用:记忆丧失的关键主要靶点。
Sci Rep. 2021 Feb 15;11(1):3001. doi: 10.1038/s41598-020-79275-1.
7
Mechanisms of tau self-aggregation and neurotoxicity.tau 自聚集和神经毒性的机制。
Curr Alzheimer Res. 2011 Sep;8(6):608-14. doi: 10.2174/156720511796717258.
8
Tau filament formation in transgenic mice expressing P301L tau.在表达P301L tau的转基因小鼠中tau细丝的形成。
J Biol Chem. 2001 Jan 5;276(1):529-34. doi: 10.1074/jbc.M006531200.
9
Evaluating triggers and enhancers of tau fibrillization.评估tau蛋白纤维化的触发因素和增强因素。
Microsc Res Tech. 2005 Jul;67(3-4):141-55. doi: 10.1002/jemt.20187.
10
Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice.突变型tau转基因小鼠中神经原纤维缠结之前的早期轴突病变。
Am J Pathol. 2007 Sep;171(3):976-92. doi: 10.2353/ajpath.2007.070345. Epub 2007 Aug 9.

引用本文的文献

1
Hiding in Plain Sight: FDA-Approved Cholesterol Drug Ezetimibe as a Treatment for Alzheimer's.隐匿于众目睽睽之下:美国食品药品监督管理局批准的胆固醇药物依泽替米贝用于治疗阿尔茨海默病
Aging Biol. 2024;2. doi: 10.59368/agingbio.20240037. Epub 2024 Oct 23.
2
Proteomic Evidence for Amyloidogenic Cross-Seeding in Fibrinaloid Microclots.纤维蛋白原样微栓中淀粉样蛋白形成的蛋白组学证据
Int J Mol Sci. 2024 Oct 8;25(19):10809. doi: 10.3390/ijms251910809.
3
The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges.tau 蛋白聚集之谜:机制见解与未来挑战。
Int J Mol Sci. 2024 May 2;25(9):4969. doi: 10.3390/ijms25094969.
4
Sedimentation and Laser Light Scattering Methods for Quantifying Synthetic Tau Aggregation Propensity.用于定量分析合成 Tau 聚集倾向的沉降和激光光散射方法。
Methods Mol Biol. 2024;2754:117-129. doi: 10.1007/978-1-0716-3629-9_7.
5
Recent Advances in Molecular Dynamics Simulations of Tau Fibrils and Oligomers.tau蛋白原纤维和寡聚体分子动力学模拟的最新进展
Membranes (Basel). 2023 Feb 26;13(3):277. doi: 10.3390/membranes13030277.
6
Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies.过度磷酸化的 tau(p-tau)与阿尔茨海默病及相关 tau 病中的药物研发。
Drug Discov Today. 2023 Mar;28(3):103487. doi: 10.1016/j.drudis.2023.103487. Epub 2023 Jan 9.
7
A Validated Method to Prepare Stable Tau Oligomers.一种稳定的 Tau 寡聚物的验证方法。
Methods Mol Biol. 2023;2551:203-224. doi: 10.1007/978-1-0716-2597-2_14.
8
Deciphering the therapeutical potentials of rosmarinic acid.解析迷迭香酸的治疗潜力。
Sci Rep. 2022 Sep 15;12(1):15489. doi: 10.1038/s41598-022-19735-y.
9
Spatial organization of protein aggregates on red blood cells as physical biomarkers of Alzheimer's disease pathology.红细胞上蛋白质聚集体的空间组织作为阿尔茨海默病病理学的物理生物标志物。
Sci Adv. 2021 Sep 24;7(39):eabj2137. doi: 10.1126/sciadv.abj2137.
10
Aggregation Condition-Structure Relationship of Mouse Prion Protein Fibrils.鼠朊蛋白纤维的聚集条件-结构关系。
Int J Mol Sci. 2021 Sep 6;22(17):9635. doi: 10.3390/ijms22179635.

本文引用的文献

1
Nucleation-dependent tau filament formation: the importance of dimerization and an estimation of elementary rate constants.成核依赖性tau蛋白纤维形成:二聚化的重要性及基本速率常数的估计
J Biol Chem. 2008 May 16;283(20):13806-16. doi: 10.1074/jbc.M800247200. Epub 2008 Mar 21.
2
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders.阿尔茨海默病及相关疾病中tau蛋白介导的神经退行性变。
Nat Rev Neurosci. 2007 Sep;8(9):663-72. doi: 10.1038/nrn2194.
3
Aggregation drives "misfolding" in protein amyloid fiber formation.聚集作用在蛋白质淀粉样纤维形成过程中驱动“错误折叠”。
Amyloid. 2007 Jun;14(2):119-31. doi: 10.1080/13506120701260059.
4
Fibrillogenic nuclei composed of P301L mutant tau induce elongation of P301L tau but not wild-type tau.由P301L突变型tau组成的原纤维形成核诱导P301L tau伸长,但不诱导野生型tau伸长。
J Biol Chem. 2007 Jul 13;282(28):20309-18. doi: 10.1074/jbc.M611876200. Epub 2007 May 25.
5
Granular tau oligomers as intermediates of tau filaments.颗粒状tau寡聚体作为tau细丝的中间体。
Biochemistry. 2007 Mar 27;46(12):3856-61. doi: 10.1021/bi061359o. Epub 2007 Mar 6.
6
The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis.通过扫描透射电子显微镜和有限蛋白酶解研究的tau配对螺旋丝的核心。
Biochemistry. 2006 May 23;45(20):6446-57. doi: 10.1021/bi052530j.
7
Characterization of paired helical filaments by scanning transmission electron microscopy.通过扫描透射电子显微镜对成对螺旋丝进行表征。
Microsc Res Tech. 2005 Jul;67(3-4):126-40. doi: 10.1002/jemt.20188.
8
Microtubule-stabilising drugs for therapy of Alzheimer's disease and other neurodegenerative disorders with axonal transport impairments.用于治疗阿尔茨海默病及其他伴有轴突运输障碍的神经退行性疾病的微管稳定药物。
Expert Opin Pharmacother. 2005 May;6(5):683-6. doi: 10.1517/14656566.6.5.683.
9
Triggers of full-length tau aggregation: a role for partially folded intermediates.全长tau蛋白聚集的触发因素:部分折叠中间体的作用。
Biochemistry. 2005 Apr 19;44(15):5862-72. doi: 10.1021/bi0500123.
10
Transgenic animal models of tauopathies.tau蛋白病的转基因动物模型。
Biochim Biophys Acta. 2005 Jan 3;1739(2-3):251-9. doi: 10.1016/j.bbadis.2004.06.014.